Effect of CO-Q 10 supplementation spermogram parameters and sexual function in infertile me
Phase 2
- Conditions
- Male infertility.Male infertility
- Registration Number
- IRCT20120215009014N322
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 70
Inclusion Criteria
Age of 18 to 40 years,
Man with primary infertility,
Abnormality in at least one of the sperm parameters (volume, concentration, number, motility, or morphology),
Body mass index less than 30,
Exclusion Criteria
Chromosomal abnormalities,
Varicocele,
Cryptorchidism,
Chronic diseases such as diabetes, kidney disease, infectious diseases, genital tract infection, thyroid disorder,
Drug or alcohol use,
Taking spermatogenic drugs (methotrexate, nitrofurantoin, colchicine or chemotherapy),
Taking pituitary suppressive drugs (testosterone, GnRh analogs),
Taking anti-androgens (cimetidine or spironolactone),
Taking alpha-blockers, antidepressants, or phenothiazide,
History of testis surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sperm volume. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm count. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm concentration. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm motility. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm morphology. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.
- Secondary Outcome Measures
Name Time Method